The Pfizer and Moderna vaccines have been on the market for almost two months, with millions of doses in circulation but months or years ahead before herd immunity can be reached. New additions from Johnson & Johnson and Novavax could significantly expand the supply.Original Article
You may also like
Gone in a Puff of Smoke? FDA’s Proposed Rule on...
FDA Appears to Be Granting Zombie Rare Pediatric...
HPM’s Larry Houck Presenting at WCF Opioid and...
Get Up To Speed on Medicare Inflation Rebates: HPM...
Into the Ashtray: FDA’s Previous Proposal to Ban...
Small Change: FDA’s Final Predetermined Change...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.